Skip to main content
Fig. 3 | Critical Care

Fig. 3

From: Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial

Fig. 3

Key clinical and biochemical parameters. a Heart rate, b mean arterial pressure, c vasoactive-inotropic score, d serum lactate, e serum creatinine, and f hourly urine output within the first 48-h of initiation of inotropic therapy. A repeated measure mixed model was used to evaluate differences in continuous variables between groups. All panels demonstrate the mean and 95% confidence intervals between the beta-blocker (blue) and no beta-blocker (red) groups at a specific time interval. BPM beats per minute

Back to article page

Critical Care

ISSN: 1364-8535